T4	Treatment 92 134	intrathecal administration of doxorubicin.
T5	Effect 68 84	toxic myelopathy
T6	Subject 29 48	a 31-year-old woman
T7	Age 31 42	31-year-old
T8	Gender 43 48	woman
T9	Drug 122 133	doxorubicin
T10	Route 92 103	intrathecal
T3	Adverse_event 85 88	due
E1	Adverse_event:T3